The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Autoimmune Disease Diagnosis-Global Market Insights and Sales Trends 2024

Autoimmune Disease Diagnosis-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1843306

No of Pages : 100

Synopsis
The global Autoimmune Disease Diagnosis market size is expected to reach US$ 4439.3 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Autoimmune Disease Diagnosis in various end use industries. The expanding demands from the Clinical Laboratories, Hospitals and Other End Users,, are propelling Autoimmune Disease Diagnosis market. Routine Laboratory Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inflammatory Markers segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Autoimmune Disease Diagnosis market, driven by demand from China, the second largest economy with some signs of stabilising, the Autoimmune Disease Diagnosis market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Autoimmune Disease Diagnosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Autoimmune Disease Diagnosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Autoimmune Disease Diagnosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Autoimmune Disease Diagnosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Autoimmune Disease Diagnosis covered in this report include Siemens, Abbott, Thermo Fisher Scientific, Danaher, Bio-Rad Laboratories, GRIFOLS, Trinity Biotech, Inova Diagnostics and HYCOR Biomedical, etc.
The global Autoimmune Disease Diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens
Abbott
Thermo Fisher Scientific
Danaher
Bio-Rad Laboratories
GRIFOLS
Trinity Biotech
Inova Diagnostics
HYCOR Biomedical
Euroimmun
Protagen
Global Autoimmune Disease Diagnosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Autoimmune Disease Diagnosis market, Segment by Type:
Routine Laboratory Tests
Inflammatory Markers
Autoantibodies and Immunologic Tests
Other Tests
Global Autoimmune Disease Diagnosis market, by Application
Clinical Laboratories
Hospitals
Other End Users
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Autoimmune Disease Diagnosis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Autoimmune Disease Diagnosis
1.1 Autoimmune Disease Diagnosis Market Overview
1.1.1 Autoimmune Disease Diagnosis Product Scope
1.1.2 Autoimmune Disease Diagnosis Market Status and Outlook
1.2 Global Autoimmune Disease Diagnosis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Autoimmune Disease Diagnosis Market Size by Region (2018-2029)
1.4 Global Autoimmune Disease Diagnosis Historic Market Size by Region (2018-2023)
1.5 Global Autoimmune Disease Diagnosis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Autoimmune Disease Diagnosis Market Size (2018-2029)
1.6.1 North America Autoimmune Disease Diagnosis Market Size (2018-2029)
1.6.2 Europe Autoimmune Disease Diagnosis Market Size (2018-2029)
1.6.3 Asia-Pacific Autoimmune Disease Diagnosis Market Size (2018-2029)
1.6.4 Latin America Autoimmune Disease Diagnosis Market Size (2018-2029)
1.6.5 Middle East & Africa Autoimmune Disease Diagnosis Market Size (2018-2029)
2 Autoimmune Disease Diagnosis Market by Type
2.1 Introduction
2.1.1 Routine Laboratory Tests
2.1.2 Inflammatory Markers
2.1.3 Autoantibodies and Immunologic Tests
2.1.4 Other Tests
2.2 Global Autoimmune Disease Diagnosis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Autoimmune Disease Diagnosis Historic Market Size by Type (2018-2023)
2.2.2 Global Autoimmune Disease Diagnosis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Autoimmune Disease Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Autoimmune Disease Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Autoimmune Disease Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Autoimmune Disease Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Autoimmune Disease Diagnosis Revenue Breakdown by Type (2018-2029)
3 Autoimmune Disease Diagnosis Market Overview by Application
3.1 Introduction
3.1.1 Clinical Laboratories
3.1.2 Hospitals
3.1.3 Other End Users
3.2 Global Autoimmune Disease Diagnosis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Autoimmune Disease Diagnosis Historic Market Size by Application (2018-2023)
3.2.2 Global Autoimmune Disease Diagnosis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Autoimmune Disease Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Autoimmune Disease Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Autoimmune Disease Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Autoimmune Disease Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Autoimmune Disease Diagnosis Revenue Breakdown by Application (2018-2029)
4 Autoimmune Disease Diagnosis Competition Analysis by Players
4.1 Global Autoimmune Disease Diagnosis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Disease Diagnosis as of 2022)
4.3 Date of Key Players Enter into Autoimmune Disease Diagnosis Market
4.4 Global Top Players Autoimmune Disease Diagnosis Headquarters and Area Served
4.5 Key Players Autoimmune Disease Diagnosis Product Solution and Service
4.6 Competitive Status
4.6.1 Autoimmune Disease Diagnosis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Siemens
5.1.1 Siemens Profile
5.1.2 Siemens Main Business
5.1.3 Siemens Autoimmune Disease Diagnosis Products, Services and Solutions
5.1.4 Siemens Autoimmune Disease Diagnosis Revenue (US$ Million) & (2018-2023)
5.1.5 Siemens Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Autoimmune Disease Diagnosis Products, Services and Solutions
5.2.4 Abbott Autoimmune Disease Diagnosis Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Profile
5.3.2 Thermo Fisher Scientific Main Business
5.3.3 Thermo Fisher Scientific Autoimmune Disease Diagnosis Products, Services and Solutions
5.3.4 Thermo Fisher Scientific Autoimmune Disease Diagnosis Revenue (US$ Million) & (2018-2023)
5.3.5 Danaher Recent Developments
5.4 Danaher
5.4.1 Danaher Profile
5.4.2 Danaher Main Business
5.4.3 Danaher Autoimmune Disease Diagnosis Products, Services and Solutions
5.4.4 Danaher Autoimmune Disease Diagnosis Revenue (US$ Million) & (2018-2023)
5.4.5 Danaher Recent Developments
5.5 Bio-Rad Laboratories
5.5.1 Bio-Rad Laboratories Profile
5.5.2 Bio-Rad Laboratories Main Business
5.5.3 Bio-Rad Laboratories Autoimmune Disease Diagnosis Products, Services and Solutions
5.5.4 Bio-Rad Laboratories Autoimmune Disease Diagnosis Revenue (US$ Million) & (2018-2023)
5.5.5 Bio-Rad Laboratories Recent Developments
5.6 GRIFOLS
5.6.1 GRIFOLS Profile
5.6.2 GRIFOLS Main Business
5.6.3 GRIFOLS Autoimmune Disease Diagnosis Products, Services and Solutions
5.6.4 GRIFOLS Autoimmune Disease Diagnosis Revenue (US$ Million) & (2018-2023)
5.6.5 GRIFOLS Recent Developments
5.7 Trinity Biotech
5.7.1 Trinity Biotech Profile
5.7.2 Trinity Biotech Main Business
5.7.3 Trinity Biotech Autoimmune Disease Diagnosis Products, Services and Solutions
5.7.4 Trinity Biotech Autoimmune Disease Diagnosis Revenue (US$ Million) & (2018-2023)
5.7.5 Trinity Biotech Recent Developments
5.8 Inova Diagnostics
5.8.1 Inova Diagnostics Profile
5.8.2 Inova Diagnostics Main Business
5.8.3 Inova Diagnostics Autoimmune Disease Diagnosis Products, Services and Solutions
5.8.4 Inova Diagnostics Autoimmune Disease Diagnosis Revenue (US$ Million) & (2018-2023)
5.8.5 Inova Diagnostics Recent Developments
5.9 HYCOR Biomedical
5.9.1 HYCOR Biomedical Profile
5.9.2 HYCOR Biomedical Main Business
5.9.3 HYCOR Biomedical Autoimmune Disease Diagnosis Products, Services and Solutions
5.9.4 HYCOR Biomedical Autoimmune Disease Diagnosis Revenue (US$ Million) & (2018-2023)
5.9.5 HYCOR Biomedical Recent Developments
5.10 Euroimmun
5.10.1 Euroimmun Profile
5.10.2 Euroimmun Main Business
5.10.3 Euroimmun Autoimmune Disease Diagnosis Products, Services and Solutions
5.10.4 Euroimmun Autoimmune Disease Diagnosis Revenue (US$ Million) & (2018-2023)
5.10.5 Euroimmun Recent Developments
5.11 Protagen
5.11.1 Protagen Profile
5.11.2 Protagen Main Business
5.11.3 Protagen Autoimmune Disease Diagnosis Products, Services and Solutions
5.11.4 Protagen Autoimmune Disease Diagnosis Revenue (US$ Million) & (2018-2023)
5.11.5 Protagen Recent Developments
6 North America
6.1 North America Autoimmune Disease Diagnosis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Autoimmune Disease Diagnosis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Diagnosis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Autoimmune Disease Diagnosis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Diagnosis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Autoimmune Disease Diagnosis Market Dynamics
11.1 Autoimmune Disease Diagnosis Industry Trends
11.2 Autoimmune Disease Diagnosis Market Drivers
11.3 Autoimmune Disease Diagnosis Market Challenges
11.4 Autoimmune Disease Diagnosis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’